Cervical cancer is one of the most common malignant tumors in gynecology. Clinical treatment for cervical cancer mainly includes surgery, radiotherapy and chemotherapy. However, for early stage cervical cancer, surgery is still the main treatment. The traditional treatment method is extensive hysterectomy. In recent years, as the incidence of cervical cancer tends to be younger and the emergence of laparoscopy and robotics, the requirements for surgical treatment are also changing, especially minimally invasive surgery is gaining more and more attention. Surgical treatment of cervical cancer is gradually becoming individualized, humanized and minimally invasive. In developed countries, the incidence and mortality rates of cervical cancer have decreased by 75% in the last 50 years, but cervical cancer still has some significant clinical problems and remains the 2nd most common female malignancy and mortality rate in developing countries. Despite universal screening for cervical cancer in 27 European countries, there are still approximately 340,000 new cases each year. More than 1.6 million deaths occur, and it is estimated that about 54% of patients are younger than 50 years old. Currently, the main treatments for cervical cancer are radiotherapy, chemotherapy and surgery. Clinically, individualized treatment plans are formulated according to the stage of cervical cancer and the fertility requirements of patients. Surgery is only suitable for early stage cervical cancer patients. In 1994, the International Federation of Gynecology and Obstetrics (FIGO) made clinical staging according to the size, depth and extent of tumor infiltration, infiltration of surrounding tissues and organs, and whether there is lymph node metastasis, in which patients with IA-IIB early stage cervical cancer are mainly treated by surgery, and the 2009 FIGO meeting adjusted the staging accordingly, and subdivided stage IIA according to the size of tumor. Rob et al. pointed out that surgery and radiotherapy have similar clinical efficacy for early-stage cervical cancer, but surgery is still the treatment of choice for young patients because it is significantly better than radiotherapy in preserving the integrity of ovarian and vaginal function and reducing long-term sequelae.